Dimethyl Itaconate Fights Oxidative Stress to Restore Blood Vessel Growth
A compound called DMI neutralizes harmful ROS in endothelial cells, restoring mitochondrial function and promoting new blood vessel formation.
Summary
Researchers tested dimethyl itaconate (DMI) as an antioxidant in human endothelial cells under oxidative stress — conditions that mimic ischemic disease. DMI significantly reduced excess reactive oxygen species (ROS), preserved cell structure and mechanical integrity, and restored mitochondrial function by boosting membrane potential and ATP production. These effects were driven by upregulation of antioxidant enzymes SOD2 and catalase. Critically, DMI also promoted cell migration and angiogenesis — the formation of new blood vessels — which is often impaired in ischemic conditions. The findings suggest DMI could be a promising therapeutic candidate for ischemic diseases where poor angiogenesis contributes to bad outcomes.
Detailed Summary
Ischemic diseases — including heart attack and peripheral artery disease — create oxygen-deprived environments that trigger a flood of reactive oxygen species (ROS) inside cells. This oxidative stress suppresses angiogenesis, the body's natural process of forming new blood vessels, worsening tissue recovery and patient prognosis. Finding safe, effective antioxidants that can restore this process is a key therapeutic goal.
Researchers from Jilin University and the Chinese Academy of Sciences investigated dimethyl itaconate (DMI), a cell-permeable derivative of itaconate, using human umbilical vein endothelial cells (HUVECs) as an oxidative stress model. Cells were exposed to hydrogen peroxide to simulate ischemic oxidative damage, with and without DMI co-treatment.
DMI demonstrated robust antioxidant activity. It significantly reduced intracellular ROS levels and protected cell morphology and cytoskeletal integrity. Notably, the Young's modulus — a measure of cellular stiffness reflecting structural health — dropped to 10.0 kPa under H2O2 stress but recovered to 24.42 kPa with DMI co-treatment, indicating preserved mechanical properties. DMI also rescued mitochondrial function, enhancing mitochondrial membrane potential and increasing ATP output.
Mechanistically, DMI upregulated superoxide dismutase 2 (SOD2) and catalase, two critical antioxidant enzymes responsible for neutralizing intracellular ROS. By protecting endothelial cells from oxidative damage, DMI restored cell migration capacity and promoted tube formation — hallmarks of functional angiogenesis.
These findings position DMI as a potentially valuable therapeutic agent for ischemic conditions. However, this is a cell-culture study only, and translation to animal models and eventually clinical use requires substantial further validation. The optimal dosing, delivery mechanisms, and systemic safety profile of DMI remain to be established.
Key Findings
- DMI significantly reduced excess intracellular ROS in H2O2-stressed HUVECs via SOD2 and catalase upregulation.
- Cell stiffness (Young's modulus) recovered from 10.0 kPa to 24.42 kPa with DMI treatment, indicating structural protection.
- DMI restored mitochondrial membrane potential and increased ATP levels, reversing mitochondrial dysfunction.
- DMI preserved cytoskeletal integrity and cell morphology under oxidative stress conditions.
- DMI promoted endothelial cell migration and angiogenesis, key processes impaired in ischemic disease.
Methodology
In vitro study using human umbilical vein endothelial cells (HUVECs) exposed to hydrogen peroxide as an oxidative stress model. DMI was co-administered at 40 μg/mL, and outcomes included ROS levels, cell mechanics via atomic force microscopy, mitochondrial membrane potential, ATP levels, enzyme expression, migration assays, and tube formation assays.
Study Limitations
This study is limited to cell culture models and does not include animal or human data, limiting direct clinical translation. Optimal dosing, bioavailability, and systemic toxicity of DMI have not been assessed. The H2O2 oxidative stress model is a simplified proxy for the complex ischemic microenvironment.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.